Abstract:
Rheumatoid arthritis (RA) is a joint disease, chronically cause permanent joint
impairment leading to inability of daily life activities. Early diagnosis and preven tive managements of RA are recommended to overcome the disease. The current
drugs provide benefits for RA patients, unfortunately could not be used for long
period and as prevention agents, due to the adverse effects. Even though clinical
and laboratory studies of pomegranate for osteoarthritis and RA had been done,
the effects of the pomegranate peel on MMP-9, TNF-α, and IL-6 of RA are still
unrevealed. TNF-α promotes inflammation process in RA and collaborates with
osteoclasts to trigger osteoporosis. IL-6 shows negative effect on osteoblasts dif ferentiation and MMP-9 stimulates cartilage degradation and inflammation medi ated by synovial fibroblast. This study measured TNF-α, IL-6, MMP-9, and ar thritis score (AS) of RA rats treated with ethanolic extract of pomegranate peel
(EPP) to evaluate its potency as a RA prevention agent. Male Lewis rats (three
groups, five each), 200 g, received 80 mg, 160 mg, and 320 mg of EPP/rat respec tively, in alternate day, within 60 days. On the 30th day, the rats were subcutane ously injected with 0,1 ml mycobacterium-complete Freund’s adjuvant (1 mg/mL)
on plantar of the right hind paws to induce RA. Serum IL-6 and TNF-α were de termined by ELISA. Immunohistochemistry processed-synovial MMP-9 slices of
ankle joints were evaluated by light microscope (400× magnification). Arthritis
score of Smit was used to determined AS. Data were analyzed by Kruskall Wallis,
Mann Whitney U, and Pearson correlation test. p < 0.05 was significant. The EPP
of 320 mg corrected serum TNF-α and IL-6, and synovial MMP-9 of RA rats (p <
0.05). No significant change was observed in arthritic score following the EPP
treatment (p > 0.05). In conclusion, the results indicate the EPP may potential to
be developed as preventive agent of rheumatoid arthritis.
